Theratechnologies Inc trades with the ticker TH on the TSX and is in the Biotechnology industry.
Overview
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Looking to invest in Theratechnologies Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
TH.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $76.787MM
PE Ratio:
Price: 8.51 (Updated: 3/12/2024 0:47:16)
Theratechnologies Inc (TH) vs Competitors in Biotechnology
Lets see how TH.TO stacks up against others in the Biotechnology asset management industry. We have identified its main peers as:Aeterna Zentaris Inc, Aptose Biosciences Inc, BELLUS Health Inc, Fennec Pharmaceuticals Inc, IMV Inc
.Biotechnology Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aeterna Zentaris Inc (AEZS) | $12.674 | N/A | 1.709 | N/A% |
| Aptose Biosciences Inc (APS) | $33.927 | N/A | -0.231 | N/A% |
| BELLUS Health Inc (BLU) | $2,470.298 | N/A | -16.428 | 0.0% |
| Fennec Pharmaceuticals Inc (FRX) | $352.565 | N/A | -21.793 | N/A% |
| IMV Inc (IMV) | $13.117 | N/A | -0.843 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Biotechnology
- Theratechnologies Inc (TH) vs Aeterna Zentaris Inc (AEZS)
- TH has higher EPS (-1.22 vs -6.47). AEZS and TH both have P/E’s under 0.
- Theratechnologies Inc (TH) vs Aptose Biosciences Inc (APS)
- TH has higher EPS (-1.22 vs -10.45). APS and TH both have P/E’s under 0.
- Theratechnologies Inc (TH) vs BELLUS Health Inc (BLU)
- BLU has higher EPS (-0.96 vs -1.22). BLU provides dividends, while TH does not. BLU and TH both have P/E’s under 0.
- Theratechnologies Inc (TH) vs Fennec Pharmaceuticals Inc (FRX)
- FRX has higher EPS (-1.01 vs -1.22). FRX and TH both have P/E’s under 0.
- Theratechnologies Inc (TH) vs IMV Inc (IMV)
- TH has higher EPS (-1.22 vs -6.11). IMV provides dividends, while TH does not. IMV and TH both have P/E’s under 0.
Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-10.32) than the industry average (-4.03), indicating attractive valuation.
How to Buy TH stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
